Hila completed her PhD at the Kirby Institute in HIV Clinical Research focusing on the effects of HIV and antiretroviral therapy on bone disease. She then worked in clinical research and operations within academia and healthcare and was part of the data and analytics team at the Federal Department of Health and Aged Care. She currently works as a Senior Clinical Research Coordinator at the Therapeutic and Vaccine Research Program at the Kirby Institute.

Senior Clinical Project Coordinator
Dr Hila Haskelberg
BSc PhD
- Publications
Publications
Journal articles
Li I; Chen AZ; Newby JM; Kladnitski N; Haskelberg H; Millard M; Mahoney A, 2022, 'The uptake and outcomes of an online self-help mindfulness programme during COVID-19', Clinical Psychologist, 26, pp. 255 - 268, http://dx.doi.org/10.1080/13284207.2022.2045866
2022
Gardner T; Schultz R; Haskelberg H; Newby JM; Wheatley J; Millard M; Faux SG; Shiner CT, 2022, 'The Effect of Adjunct Telephone Support on Adherence and Outcomes of the Reboot Online Pain Management Program: Randomized Controlled Trial', Journal of Medical Internet Research, 24, http://dx.doi.org/10.2196/30880
2022
Shiner CT; Gardner T; Haskelberg H; Li I; Faux SG; Millard M; Mahoney AEJ, 2022, 'The Uptake and Effectiveness of a Multidisciplinary Online Program for Managing Chronic Pain before and During the COVID-19 Pandemic', Pain Medicine (United States), 23, pp. 1621 - 1630, http://dx.doi.org/10.1093/pm/pnac049
2022
Sharrock M; Mahoney A; Haskelberg H; Millard M; Newby J, 2021, 'The uptake and outcomes of Internet cognitive behavioural therapy for health anxiety symptoms during the COVID-19 pandemic', Journal of Anxiety Disorders
2021
Loughnan S; Wallace M; Joubert A; Haskelberg H; Andrews G; Newby JM, 2018, 'A systematic review of psychological treatments for clinical anxiety during the perinatal period', Archives of Women’s Mental Health.
2018
Loughnan S; Newby JM; Haskelberg H; Mahoney A; Kladnitski N; Smith J; Black E; Holt C; Milgrom J; Andrews G, 2018, 'Internet-based cognitive behavioural therapy (iCBT) for perinatal anxiety and depression versus treatment as usual: study protocol for a randomized controlled trial', Trials
2018
Berthon-Jones N; Courtney-Vega K; Donaldson A; Haskelberg H; Emery S; Puls R, 2015, 'Assessing site performance in the Altair study, a multinational clinical trial', Trials, 16, http://dx.doi.org/10.1186/s13063-015-0653-x
2015
Haskelberg H; Mallon PWG; Hoy J; Amin J; Moore C; Phanuphak P; Ferret S; Belloso WH; Boyd MA; Cooper DA; Emery S, 2014, 'Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ ritonavir compared with standard second-line therapy', Journal of Acquired Immune Deficiency Syndromes, 67, pp. 161 - 168, http://dx.doi.org/10.1097/QAI.0000000000000288
2014
Haskelberg H; Cordery DV; Amin J; Kelleher AD; Cooper DA; Emery S, 2014, 'HLA Alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0093333
2014
Haskelberg H; Pocock N; Amin J; Ebeling PR; Emery S; Carr A, 2014, 'Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0094858
2014
Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, 7, pp. e38377, http://dx.doi.org/10.1371/journal.pone.0038377
2012
Byakwaga H; Purcell DJ; French MA; Amin J; Lewin S; Haskelberg H; Kelleher AD; Garsia RJ; Boyd MA; Cooper DA; Emery S, 2011, 'Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4 + T-cell response: A randomized controlled trial', Journal of Infectious Diseases, 204, pp. 1532 - 1540, http://jid.oxfordjournals.org/content/204/10/1532
2011
Haskelberg H; Carr AD; Emery S, 2011, 'Bone turnover markers in HIV disease', AIDS Reviews, 13, pp. 240 - 250, http://www.aidsreviews.com/files/2011_13_4_240-250.pdf
2011
Smith FA; Haskelberg H; Tracey DJ; Moalem-Taylor G, 2008, 'Role of histamine H-3 and H-4 receptors in mechanical hyperalgesia following peripheral nerve injury', Neuroimmunomodulation, 14, pp. 317 - 325, http://dx.doi.org/10.1159/000125048
2008